Content deleted Content added
No edit summary |
Carlo Banez (talk | contribs) |
||
Line 56:
*[http://seekingalpha.com/article/270085-exelixis-looming-cancer-conference-a-favorable-swing-trade-opportunity Exelixis: Looming Cancer Conference a Favorable Swing Trade Opportunity]
*[http://www.asco.org/ascov2/Meetings/Abstracts?&vmview=abst_detail_view&confID=65&abstractID=35249 A phase II study of XL184 in patients (pts) with progressive glioblastoma multiforme (GBM) in first or second relapse. 2009]
{{Extracellular chemotherapeutic agents}}
[[Category:Quinolines]]
| |||